The majority of the letter focuses on website copy, printed information packets, customer testimonials and other materials that appear, at least to the FDA, to represent claims made by AMARC that the Poly-MVA supplement is ???intended for use in the cure, mitigation, treatment, or prevention of disease,??? thus making it a drug subject to FDA regulatory approval.